Delivery Considerations of Cognitive Processing Therapy for PTSD

Overview

Review treatment outcomes of modifications to standard delivery of CPT for PTSD that are delivered as routine care at in VA outpatient clinic.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: August 1, 2020

Detailed Description

Background and Introduction Cognitive Processing Therapy (CPT) is an evidenced based psychotherapy for PTSD. It is considered a first line treatment and has ample evidence supporting it's effectiveness (ISTSS and VA/DOD clinical practice guidelines). This therapy is manualized and a framework is provided to ensure consistent delivery. Additionally, the VA Office of Mental Health Operations sponsors training and dissemination of CPT throughout the VA system and the PI of this study is a trainer and consultant of this therapy. Flexibility exists in the protocol and CPT can be delivered in unorthodox modalities such as telehealth (Moreland et al, 2015) and on compressed time schedules (Held et al, 2020; Bryan et al, 2018). While the literature supports the effectiveness of these interventions in unique settings, no known studies have looked at outcome data of real-world outpatient clinics. The PTSD Clinical Team provides CPT as part of it's standard care with a variety of adaptations. The team practices measurement based care and routinely collects self-report symptom inventories to track patient progress. This study aims to use data collected as part of standard care in this clinic to evaluate the effectiveness of these treatment adaptations in this setting. Purpose and Objectives The purpose of this study is to explore the impact of how CPT for PTSD is delivered. Initial areas of review will include in person vs. telehealth delivery and timing (daily vs. weekly).

Interventions

  • Behavioral: CPT for PTSD
    • Evidence based psychotherapy for PTSD

Arms, Groups and Cohorts

  • Vets
    • Veterans receiving care from the PTSD Clinical Team at the Salt Lake City VAMC. All participants are adults with a diagnosis of PTSD. This study plans on reviewing data collected as part of standard clinical practices. The study will have no impact on the treatment provided to the patient.

Clinical Trial Outcome Measures

Primary Measures

  • PTSD Checklist 5
    • Time Frame: Through study completion, an average of 12 sessions (3 months)
    • Self report PTSD symptom inventory

Secondary Measures

  • PHQ-9
    • Time Frame: Through study completion, an average of 12 sessions (3 months)
    • Self report depression symptom inventory

Participating in This Clinical Trial

Inclusion Criteria

  • PTSD diagnosis – Veterans eligible for VA care – Treatment seeking Veterans Exclusion Criteria:

  • PTSD not priority of treatment due to comorbidity, safety, etc. All patients that would be treated for PTSD in outpatient clinic are included.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • VA Salt Lake City Health Care System
  • Provider of Information About this Clinical Study
    • Principal Investigator: Harrison R Weinstein, Principal Invesigator – VA Salt Lake City Health Care System
  • Overall Official(s)
    • Harrison R Weinstein, PhD, Principal Investigator, VA Salt Lake City

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.